The store will not work correctly when cookies are disabled.
4-(2,6-dichlorobenzyl)-2-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3(2H)-one
ID: ALA5201988
PubChem CID: 168291960
Max Phase: Preclinical
Molecular Formula: C18H16Cl2N2O2
Molecular Weight: 363.24
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(-n2[nH]c(C)c(Cc3c(Cl)cccc3Cl)c2=O)cc1
Standard InChI: InChI=1S/C18H16Cl2N2O2/c1-11-14(10-15-16(19)4-3-5-17(15)20)18(23)22(21-11)12-6-8-13(24-2)9-7-12/h3-9,21H,10H2,1-2H3
Standard InChI Key: XIPWUAOKHPWXQM-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
-0.6873 0.0666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3548 0.5515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0998 1.3362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2748 1.3362 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0199 0.5515 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6873 -0.7584 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.5124 2.0508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1518 0.3379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3654 -0.4590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7820 -1.0427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9956 -1.8371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7929 -2.0508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3747 -1.4713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1657 -0.6735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7493 -0.0901 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-1.0646 -0.5708 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.7771 0.3379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3608 0.9213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1551 0.7076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3687 -0.0896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7894 -0.6712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9916 -0.4624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1657 -0.3031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7493 0.2802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 1 1 0
1 6 2 0
3 7 1 0
2 8 1 0
8 9 1 0
10 9 2 0
11 10 1 0
12 11 2 0
13 12 1 0
14 13 2 0
9 14 1 0
14 15 1 0
10 16 1 0
17 5 1 0
18 17 2 0
19 18 1 0
20 19 2 0
21 20 1 0
17 22 1 0
22 21 2 0
20 23 1 0
23 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 363.24 | Molecular Weight (Monoisotopic): 362.0589 | AlogP: 4.38 | #Rotatable Bonds: 4 |
Polar Surface Area: 47.02 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.25 | CX Basic pKa: 1.16 | CX LogP: 4.30 | CX LogD: 3.95 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.75 | Np Likeness Score: -1.01 |
References
1. Nizi MG, Maksimainen MM, Lehtiö L, Tabarrini O.. (2022) Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules., 65 (11.0): [PMID:35608571] [10.1021/acs.jmedchem.2c00281] |